Physician profile
Sara E Phelps
NPI 1154346088
$1,021.33
in general payments reported to CMS, 2019-2025
21 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $61.05 · 2021: $134 · 2022: $163 · 2023: $107 · 2024: $117 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $166.45 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $93.16 | 2019-2021 | |
| Allergan, INC. | $81.53 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $79.40 | 2019 | |
| Kala Pharmaceuticals, INC. | $69.10 | 2021-2022 | |
| Alcon Vision LLC | $64.82 | 2019-2024 | Simbrinza, Total30 |
| Harrow Eye, LLC | $62.25 | 2025 | Vevye |
| Dompe US, INC. | $58.96 | 2021-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $56.57 | 2025 | Omidria |
| Bausch & Lomb Americas INC. | $55.34 | 2024-2025 | Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $41.55 | 2020-2023 | |
| Abbvie INC. | $32.04 | 2022 | |
| Coopervision INC. | $26.06 | 2019 | |
| Glaukos Corporation | $21.73 | 2022 | |
| Horizon Therapeutics Plc | $19.95 | 2023 | Tepezza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.68 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $16.47 | 2024 | Xdemvy |
| Rxsight INC | $15.17 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $14.67 | 2019 | |
| Oyster Point Pharma, INC. | $14.50 | 2022 | |
| Mallinckrodt Hospital Products INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Phelps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.